Patents by Inventor Cyril Gay

Cyril Gay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and Method of an Orally Administered Antimicrobial Peptide Vectored in a Bacterial Expression Vehicle
    Publication number: 20240102027
    Abstract: The inventive subject matter includes an antimicrobial peptide vectored composition made of a bacterial protein expression vehicle expressing one or more recombinant antimicrobial peptide effector molecules. More specifically these novel recombinant antimicrobial peptide effector molecules exhibit preferential antimicrobial activity. In some embodiments, the antimicrobial activity is facilitated via interaction with the lipid bilayer of the parasitic cell form, leading to membrane pore formation and resulting in cell lysis. The utility of the current inventive subject matter has demonstrated a reduced viability of Eimeira acervulina sporozoites was shown in vitro using a sporozoite killing assay.
    Type: Application
    Filed: October 4, 2023
    Publication date: March 28, 2024
    Applicants: US BIOLOGIC, INC, The United States of America as represented by the Secretary of Agriculture
    Inventors: Jolieke G. Van Oosterwijk, Luciana Meirelles Richer, Douglas Steven Zetechka, JR., Hyun Soon Lillehoj, Woohyun Kim, Cyril Gay, Christopher Anthony Przybyszewski
  • Hyperimmunized egg product for treatment of necrotic enteritis in poultry
    Patent number: 11230590
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: January 25, 2022
    Assignees: Arkion Life Sciences, LLC, United States of America, as Represented by the Secretary of Agriculture
    Inventors: Hyun S. Lillehoj, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay
  • HYPERIMMUNIZED EGG PRODUCT FOR TREATMENT OF NECROTIC ENTERITIS IN POULTRY
    Publication number: 20200002404
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Application
    Filed: September 18, 2019
    Publication date: January 2, 2020
    Applicants: The United States of America, as Represented by the Secretary of Agriculture, Arkion Life Sciences, LLC
    Inventors: Hyun S. Lillehoj, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay
  • Hyperimmunized egg product for treatment of necrotic enteritis in poultry
    Patent number: 10450364
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: October 22, 2019
    Assignees: Arkion Life Sciences, LLC, United Sates of America, as Represented by the Secretary of Agriculture
    Inventors: Hyun S. Lillehoj, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay
  • HYPERIMMUNIZED EGG PRODUCT FOR TREATMENT OF NECROTIC ENTERITIS IN POULTRY
    Publication number: 20180230199
    Abstract: In one aspect, the present invention is directed to a method for preventing or treating necrotic enteritis by administering a hyperimmunized egg product obtained from an egg-producing animal to an avian. The hyperimmunized egg product may contain an antibody specific to an antigen selected from the group consisting of Clostridium perfringens ?-toxin, Clostridium perfringens elongation factor Tu (EF-Tu), Clostridium perfringens necrotic enteritis B-like (NetB) toxin, Clostridium perfringens Pyruvate: Ferredoxin oxidoreductase (PFO), and Eimeria tenella elongation factor 1-alpha.
    Type: Application
    Filed: February 13, 2018
    Publication date: August 16, 2018
    Applicants: The United States of America, as represented by the Secretary of Agriculture, Arkion Life Sciences, LLC
    Inventors: Hyun S. Lillehoh, Earnest W. Porta, Samuel V. Walker, Leslie A. Confer, Ujvala Deepthi Gadde, Cyril Gay